Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review. Neurology. 2017 Sep 05; 89(10):1069-1077.
View in:
PubMed
subject areas
Adult
Anti-Inflammatory Agents
Autoantibodies
Female
Follow-Up Studies
Humans
Immunologic Factors
Male
Middle Aged
Myasthenia Gravis
Prednisone
Prospective Studies
Receptor Protein-Tyrosine Kinases
Receptors, Cholinergic
Rituximab
Severity of Illness Index
Single-Blind Method
Treatment Outcome
authors with profiles
Katherine Michelle Ruzhansky